Venous Thromboembolism

18 competing products in clinical development for Venous Thromboembolism.

Pipeline by Phase

Pre-clinical3

Phase 11

Phase 22

Phase 2/33

Phase 39

All Products (18)

Product	Company	Stage	Status	Hype
15mg DU-176b + 30mg DU-176b + Fondaparinux	Daiichi Sankyo	Phase 3	Completed	40
DU-176b (edoxaban) + Enoxaparin sodium 20mg	Daiichi Sankyo	Phase 3	Completed	40
edoxaban + enoxaparin sodium	Daiichi Sankyo	Phase 3	Completed	40
edoxaban tosylate(DU-176b) + low molecular weight heparin/unfractionated heparin + warfarin	Daiichi Sankyo	Phase 3	Completed	40
YM150	Astellas Pharma	Phase 3	Completed	40
YM150	Astellas Pharma	Phase 3	Completed	40
YM150	Astellas Pharma	Phase 3	Completed	40
YM150	Astellas Pharma	Phase 3	Completed	40
YM150 + enoxaparin	Astellas Pharma	Phase 2/3	Completed	38
YM150 + Placebo + Enoxaparin	Astellas Pharma	Phase 2/3	Completed	38
YM150 + Placebo + Enoxaparin	Astellas Pharma	Phase 2/3	Completed	38
DU-176b 15mg + DU-176b 30mg + Enoxaparin sodium 20 mg (=2000IU)	Daiichi Sankyo	Phase 2	Completed	35
DU-176b + DU-176b + DU-176b + DU-176b + Placebo	Daiichi Sankyo	Phase 2	Completed	35
dalteparin injection	Eisai	Phase 3	Terminated	32
ONO-7684 + ONO-7684 Placebo	Ono Pharmaceutical	Phase 1	Completed	29
Edoxaban	Daiichi Sankyo	Pre-clinical	Completed	26
Edoxaban	Daiichi Sankyo	Pre-clinical	Completed	26
Dalteparin sodium + Dalteparin sodium/aspirin	Eisai	Pre-clinical	Completed	26